Home/Filings/4/0001971702-25-000009
4//SEC Filing

Wai Conrad 4

Accession 0001971702-25-000009

CIK 0001801170other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 4:46 PM ET

Size

8.1 KB

Accession

0001971702-25-000009

Insider Transaction Report

Form 4
Period: 2025-10-31
Wai Conrad
CEO, Counterpart Health
Transactions
  • Tax Payment

    Class A Common Stock

    2025-10-31$3.53/sh27,930$98,5931,150,085 total
  • Tax Payment

    Class A Common Stock

    2025-10-31$3.53/sh96,448$340,4611,178,015 total
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    1,610,482
Footnotes (3)
  • [F1]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025.
  • [F2]Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2025.
  • [F3]Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.

Issuer

CLOVER HEALTH INVESTMENTS, CORP. /DE

CIK 0001801170

Entity typeother

Related Parties

1
  • filerCIK 0001971702

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:46 PM ET
Size
8.1 KB